205 related articles for article (PubMed ID: 8178059)
1. [Allogenic reaction, a model of autoimmunity].
Goldman M; Abramowicz D
Rev Prat; 1994 Jan; 44(1):53-6. PubMed ID: 8178059
[TBL] [Abstract][Full Text] [Related]
2. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction.
Eisenberg R; Choudhury A
Methods Mol Med; 2004; 102():273-84. PubMed ID: 15286390
[TBL] [Abstract][Full Text] [Related]
3. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity.
Goldman M; Druet P; Gleichmann E
Immunol Today; 1991 Jul; 12(7):223-7. PubMed ID: 1832281
[TBL] [Abstract][Full Text] [Related]
4. Preferential activation of Th2 cells in chronic graft-versus-host reaction.
De Wit D; Van Mechelen M; Zanin C; Doutrelepont JM; Velu T; Gérard C; Abramowicz D; Scheerlinck JP; De Baetselier P; Urbain J
J Immunol; 1993 Jan; 150(2):361-6. PubMed ID: 8419469
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
[TBL] [Abstract][Full Text] [Related]
7. TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals.
Dubey C; Bellon B; Druet P
Eur Cytokine Netw; 1991; 2(3):147-52. PubMed ID: 1832570
[No Abstract] [Full Text] [Related]
8. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
9. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
10. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
11. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring of graft versus host (GVH) reaction and host versus graft (HVG) reaction].
Tanaka S; Orita K
Nihon Rinsho; 1990 Sep; 48(9):2041-7. PubMed ID: 2232208
[No Abstract] [Full Text] [Related]
13. The nephritogenic T cell response in murine chronic graft-versus-host disease.
Meyers CM; Tomaszewski JE; Glass JD; Chen CW
J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune syndrome associated with host versus graft reaction in the mouse].
Goldman M; Abramowicz D; Doutrelepont JM
Nephrologie; 1989; 10(3):109-11. PubMed ID: 2691905
[TBL] [Abstract][Full Text] [Related]
15. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease.
Chen F; Maldonado MA; Madaio M; Eisenberg RA
J Immunol; 1998 Dec; 161(11):5880-5. PubMed ID: 9834067
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy is developed under Th2 environment in chronic graft-versus-host disease.
Nakashima H
Med Hypotheses; 2007; 69(4):787-91. PubMed ID: 17398013
[TBL] [Abstract][Full Text] [Related]
18. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
20. Lupus-like autoimmunity in murine graft-versus-host disease.
Portanova JP; Kotzin BL
Concepts Immunopathol; 1988; 6():119-40. PubMed ID: 3292048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
